Resuscitations: Stem Cells and the Crisis of Old Age

Body & Society

Volumn 12, Issue 1, 2006, Pages 1-23

  Cooper, Melinda ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33646752410     PISSN: 1357034X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1357034X06061196     Document Type: Article

References (56)

1. Andrews, Lori and Dorothy Nelkin (2001) Body Bazaar: The Market for Human Tissue in theBiotechnology Age. New York: Crown Publishers.
2. Bak, Per (1996) How Nature Works: The Science of Self-organizedCriticality. New York: Springer Verlag.
3. Baud, Jean-Pierre (1993) L'Affaire de la main volée: unehistoire juridique du corps. Paris: Seuil.
4. Bauman, Zygmunt (2004) Wasted Lives. Cambridge: Polity.
5. Bell, Eugene (2000) ‘Tissue Engineering inPerspective’, pp. xxxv–xli in Robert P. Lanza, Robert Langer and Joseph Vacanti (eds) Principles of Tissue Engineering. San Diego: Academic Press.
6. Bensaïd, Daniel (2002) Marx for Our Times: Adventures and Misadventures of aCritique, trans. Gregory Elliott. London and New York: Verso.
7. Bowring, Finn (1993) Science, Seeds and Cyborgs: Biotechnology and theAppropriation of Life. London and New York: Verso.
8. Brenner, Robert (2002) The Boom and the Bubble: The US in the WorldEconomy. London and New York: Verso.
9. Cooper, Melinda (2003) ‘Rediscovering the Immortal Hydra: Stem Cells and the Question of Epigenesis’, Configurations 11(1): 1–26.
10. Debru, Claude (1998) Philosophie de l'inconnu: le vivant et larecherche. Paris: Presses Universitaires de France.
11. Drahos, Peter and John Braithwaite (2003) Information Feudalism: Who Owns the Knowledge Economy? New York: Norton.
12. Duffy, Diane T. (2001) ‘Background and Legal Issues Related toStem Cell Research’, ‘Georgia Firm Could TestGeron-Wisconsin Stem Cell Advantage’, San FranciscoChronicle 20 August.
13. Dyer-Witheford, Nick (1999) Cyber-Marx: Cycles and Circuits of Struggle inHigh-Technology Capitalism. Urbana and Chicago: University of Illinois Press.
14. Edelman, Bernard (1989) ‘Le Droit et le vivant’, La Recherche 20: 966–976.
15. European Group on Ethics in Science and New Technologies to the European Commission (2002) Opinion on Ethical Aspects of Patenting InventionsInvolving Human Stem Cell Research. Luxembourg: Office for Official Publications ofthe European Commission.
16. Fletcher, Liz (2001) ‘Re-engineering the Business of Regenerative Medicine’, Nature Biotechnology 19: 204–205.
17. Franklin, Sarah (2001) ‘Culturing Biology: Cell Lines for the Second Millennium’, Health: An Interdisciplinary Journal for the Social Study ofHealth, Illness and Medicine 5(3): 335–354.
18. Georgescu-Roegen, Nicholas (1971) The Entropy Law and the Economic Process. Cambridge, MA: Harvard University Press.
19. Geron Corporation (2000) Annual Report. URL (consulted October 2005): www.geron.com
20. Geron Corporation (2003a) Annual Report. URL (consulted October 2005): www.geron.com
21. Geron Corporation (2003b) ‘Form 10-Q for GeronCorporation’, Quarterly Report 12 November: 1–1.
22. Hawken, Paul, Amory B. Lovins and L. Hunter Lovins (2000) Natural Capitalism: The Next IndustrialRevolution. London: Earthscan Publications.
23. Hayflick, Leonard (1982) ‘Biological Aspects ofAging’, pp. 223–258 in Samuel H. Preston (ed.) Biological and Social Aspects of Mortality and the Length ofLife. Liège: Ordina Editions.
24. Hayflick, Leonard (1998) ‘How and Why We Age’, Experimental Gerontology 33(7–8): 639–653.
25. Hayflick, Leonard (2000) ‘The Future of Ageing (Insight Commentary)’, Nature 408: 267–269.
26. Kauffman, Stuart (2000) Investigations. Oxford: Oxford University Press.
27. Landecker, Hannah (2003) ‘On Beginning and Ending with Apoptosis:Cell Death and Biomedicine’, pp.23–59 in Sarah Franklin and Margaret Lock (eds) Remaking Life and Death: Toward an Anthropology of theBiosciences. Oxford and Santa Fe: School of AmericanResearch Press.
28. Lawrence, Susan C. (1998) ‘Beyond the Grave – the Use andMeaning of Human Body Parts: A Historical Introduction’, pp.111–142 in Robert F. Weir (ed.) Stored Tissue Samples: Ethical, Legal and Public PolicyImplications. Iowa City: University of Iowa Press.
29. Lock, Margaret (2002) ‘The Alienation of Body Tissue and theBiopolitics of Immortalized Cell Lines’, pp.63–92 in Nancy Scheper-Hughes and Loïc Wacquant (eds) Commodifying Bodies. London, Thousand Oaks, New Delhi: Sage.
30. Loeffler, Markus and Christopher S. Potten (1997) ‘Stem Cells and Cellular Pedigrees– a Conceptual Introduction’, in C.S. Potten (ed.) Stem Cells. London: Harcourt Brace and Co.
31. Marazzi, Christian (2002) Capitale e linguaggio: dalla New Economyall'economia di guerra. Rome: DeriveApprodi.
32. Marx, Karl (1977) Capital: A Critique of Political Economy, vol.1, trans. Samuel Moore and Edward Aveling, ed. Frederick Engels. Moscow: Progress Publishers.
33. Marx, Karl (1981) Capital, vol. 3, trans. David Fernbach.Harmondsworth, Middlesex: Penguin.
34. Marx, Karl (1993) Grundrisse: Foundations of the Critique of PoliticalEconomy, trans. Martin Nicolaus. Harmondsworth, Middlesex: Penguin.
35. Minns, Richard (2001) The Cold War in Welfare: Stock Markets versusPensions. London and New York: Verso.
36. Neilson, Brett (2003) ‘Globalization and the Biopolitics of Aging’, CR: The New Centennial Review 3: 161–186.
37. Orléan, André (1999) Le Pouvoir de la finance. Paris: Odile Jacob.
38. Pederson, Roger A. (1999) ‘Ethics and Embryonic Cells’, Scientific American 280(April): 47–47.
39. Perelman, Michael (2002) Steal This Idea: Intellectual Property Rights and theCorporate Confiscation of Creativity. New York: Palgrave.
40. Petit-Zeman, Sophie (2001) ‘Regenerative Medicine’, Nature Biotechnology 19: 201–206.
41. Pignarre, Philippe (2003) Le Grand Secret de l'industriepharmaceutique. Paris: La Découverte.
42. Pignarre, Philippe (2004) Comment sauver (vraiment) la secu. Paris: La Découverte.
43. Prigogine, Ilya and Isabelle Stengers (1985) Order out of Chaos: Man's New Dialogue withNature. London: Fontana.
44. Rao, Mahendra S. and Mark P. Mattson (2001) ‘Stem Cells and Aging: Expanding the Possibilities’, Mechanisms of Ageing and Development 122(7): 713–734.
45. Rubin, Harry (2002) ‘Promise and Problems in Relating Senescence In Vitro to Aging In Vivo’, Archives of Gerontology and Geriatrics 34: 275–286.
46. Scheper-Hughes, Nancy and Loïc Wacquant (eds) (2002) Commodifying Bodies. London, Thousand Oaks, New Delhi: Sage.
47. Shostak, Stanley (1998) Death of Life: The Legacy of Molecular Biology. London: Macmillan.
48. Shostak, Stanley (2002) Becoming Immortal: Combining Cloning and Stem-cellTherapy. New York: State University of New York Press.
49. Slater, Dashka (2002) ‘HumouseTM’, Legal Affairs November–December. URL (consulted October2005): www.legalaffairs.org/issues/November-December-2002/feature_slater_novdec2002.html
50. Strathern, Marilyn (1999) ‘Potential Property: Intellectual Rightsand Property in Persons’, pp.161–177 in Property, Substance and Effect:Anthropological Essays on Persons and Things. London: Athlone Press.
51. Thomson, James A., Joseph Itskovitz-Eldor, Sander S. Shapiro, Michelle A. Walknitz, Jennifer J. Swiergel, Vivienne S. Marshall anf Jeffrey M. Jones (1998) ‘Embryonic Stem Cell Lines Derived from Human Blastocysts’, Science 282: 1145–1147.
52. Waldby, Catherine (2002) ‘Stem Cells, Tissue Cultures and the Production of Biovalue’, Health: An Interdisciplinary Journal for the Social Study ofHealth, Illness and Medicine 6(3): 305–323.
53. Waldby, Catherine and Susan Squier (2003) ‘Ontogeny, Ontology and Phylogeny: Embryonic Life and Stem Cell Technologies’, Configurations 11: 27–46.
54. Wilkie, Dana (2004) ‘Stealth Stipulation Shadows Stem Cell Research’, The Scientist 18(4): 42–42.
55. World Bank (1994) Averting the Old Age Crisis: Policies to Protect theOld and Promote Growth. Oxford: Oxford University Press.
56. Zeller, Christian (2005) ‘Innovation Systems in Biotechnology in aFinance Dominated Accumulation Regime’, 8 April. URL (consultedOctober 2005): http://www.geog.ox.ac.uk/research/economy/aag_2005/authors15.pdf